FRIDAY, APRIL 24, 2020: 8: 30 AM–10: 00 AM: CONTRACEPTION/FAMILY PLANNING: SECOND PLACE
Long, Jill MD, MPH, MHS; Schreiber, Courtney MD, MPH; Creinin, Mitchell D. MD; Kaneshiro, Bliss MD, MPH; Nanda, Kavita MD, MPH; Blithe, Diana PhD
NICHD, Bethesda, MD
Financial Disclosure: Mitchell Creinin: Danco (Consultant/Advisory Board); Estetra (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Exeltis (Consultant/Advisory Board); HRA Pharma (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Lupin (Consultant/Advisory Board); Medicines360 (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Merck & Co. (Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Sebela (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support). Bliss Kaneshiro: Contramed Pharmaceuticals (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Gynuity Health Projects (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Merck (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support); Mithra Pharmaceuticals (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support). Diana Blithe: HRA Pharma (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support, Principal Investigator on an NICHD Cooperative Research and Development Agreement which has produced inventions that result in royalties for the inventors and for the Institute.). The other authors did not report any potential conflicts of interest.
